000 | 01035 a2200301 4500 | ||
---|---|---|---|
005 | 20250513035945.0 | ||
264 | 0 | _c19951019 | |
008 | 199510s 0 0 eng d | ||
022 | _a0140-6736 | ||
024 | 7 |
_a10.1016/s0140-6736(95)91662-8 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aClements, J | |
245 | 0 | 0 |
_aDrugs and mental health. _h[electronic resource] |
260 |
_bLancet (London, England) _cSep 1995 |
||
300 |
_a847 p. _bdigital |
||
500 | _aPublication Type: Comment; Letter | ||
650 | 0 | 4 |
_aAnti-Anxiety Agents _xadverse effects |
650 | 0 | 4 |
_aAntipsychotic Agents _xadministration & dosage |
650 | 0 | 4 | _aBenzodiazepines |
650 | 0 | 4 | _aDrug Combinations |
650 | 0 | 4 | _aDrug Interactions |
650 | 0 | 4 | _aHealth Education |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aMental Disorders _xdrug therapy |
650 | 0 | 4 |
_aPsychotropic Drugs _xadverse effects |
773 | 0 |
_tLancet (London, England) _gvol. 346 _gno. 8978 _gp. 847 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0140-6736(95)91662-8 _zAvailable from publisher's website |
999 |
_c7674206 _d7674206 |